{"count": 2, "results": [{"_id": "18719319", "pmid": 18719319, "title": "Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: it is never too late for the pretreatment.", "journal": "J Pharmacol Sci", "authors": ["Todorovic Z", "Nesic Z", "Stojanović R", "Basta-Jovanović G", "Radojevic-Skodrić S", "Velicković R", "Chatterjee PK", "Thiemermann C", "Prostran M"], "date": "2008-08-01T00:00:00Z", "doi": "10.1254/jphs.sc0070374", "meta_date_publication": "2008 Aug", "meta_volume": "107", "meta_issue": "4", "meta_pages": "465-70", "score": 50059.965, "text_hl": "However, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ injected 30 min before @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischemia@@@ was 30% - 75% more effective in reduction of serum @CHEMICAL_Creatinine @CHEMICAL_MESH:D003404 @@@creatinine@@@ levels and interstitial @DISEASE_Edema @DISEASE_MESH:D004487 @@@edema@@@ score, while its injections 5 and 30 min before reperfusion were 25% - 60% more effective in reduction of @<m>DISEASE_Kidney_Tubular_Necrosis_Acute</m> @DISEASE_MESH:D007683 @@@tubular necrosis@@@ score and fractional excretion of Na+. ", "citations": {"NLM": "Todorovic Z, Nesic Z, Stojanović R, Basta-Jovanović G, Radojevic-Skodrić S, Velicković R, Chatterjee PK, Thiemermann C, Prostran M. Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: it is never too late for the pretreatment. J Pharmacol Sci. 2008 Aug;107(4):465-70. PMID: 18719319", "BibTeX": "@article{18719319, title={Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: it is never too late for the pretreatment.}, author={Todorovic Z and Nesic Z and Stojanović R and Basta-Jovanović G and Radojevic-Skodrić S and Velicković R and Chatterjee PK and Thiemermann C and Prostran M}, journal={J Pharmacol Sci}, volume={107}, number={4}, pages={465-70}}"}}, {"_id": "29067120", "pmid": 29067120, "title": "Simvastatin attenuates renal ischemia/reperfusion injury from oxidative stress via targeting Nrf2/HO-1 pathway.", "journal": "Exp Ther Med", "authors": ["Zhang Y", "Rong S", "Feng Y", "Zhao L", "Hong J", "Wang R", "Yuan W"], "date": "2017-11-01T00:00:00Z", "doi": "10.3892/etm.2017.5023", "meta_date_publication": "2017 Nov", "meta_volume": "14", "meta_issue": "5", "meta_pages": "4460-4466", "score": 50051.0, "text_hl": "@CHEMICAL_Hematoxylin @CHEMICAL_MESH:D006416 @@@Hematoxylin@@@-eosin staining revealed no obvious morphological @DISEASE_Abnormalities_Drug_Induced @DISEASE_MESH:D000014 @@@abnormalities@@@ in the sham group, while I@DISEASE_Ring_Chromosome_20_Syndrome @DISEASE_MESH:C580424 @@@/R@@@ led to notable @DISEASE_Adenocarcinoma @DISEASE_MESH:D000230 @@@tubular cell swelling@@@, vacuolization, cast formation and @<m>DISEASE_Kidney_Tubular_Necrosis_Acute</m> @DISEASE_MESH:D007683 @@@tubular necrosis@@@, which was rescued by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Zhang Y, Rong S, Feng Y, Zhao L, Hong J, Wang R, Yuan W. Simvastatin attenuates renal ischemia/reperfusion injury from oxidative stress via targeting Nrf2/HO-1 pathway. Exp Ther Med. 2017 Nov;14(5):4460-4466. PMID: 29067120", "BibTeX": "@article{29067120, title={Simvastatin attenuates renal ischemia/reperfusion injury from oxidative stress via targeting Nrf2/HO-1 pathway.}, author={Zhang Y and Rong S and Feng Y and Zhao L and Hong J and Wang R and Yuan W}, journal={Exp Ther Med}, volume={14}, number={5}, pages={4460-4466}}"}}]}